Insider trade

Diamedica Therapeutics (DMAC)10% owner bought ~$318K

STAHLBERG JAN, 10% owner at Diamedica Therapeutics, bought ~$318K of Diamedica Therapeutics shares.

~$318K
Approx. value · 40K sh @ $7.89: 8.75M
Holds after · shares reported

Traded: Nov 24, 2025
Filed: Dec 8, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

Nov 12, 2025Company filing · Form 8-K · ResultsReported its results
Nov 17, 2025Insider10% owner purchased ~$1.22M of DMAC shares in the open market
Nov 18, 2025Insider10% owner purchased ~$1.23M of DMAC shares in the open market
Nov 19, 2025Insider10% owner purchased ~$1.73M of DMAC shares in the open market
Nov 20, 2025Insider10% owner purchased ~$951K of DMAC shares in the open market
Nov 21, 2025Insider10% owner purchased ~$1.55M of DMAC shares in the open market
Nov 24, 2025 · this disclosureInsider10% owner purchased ~$318K of DMAC shares in the open market

What came next

Nov 25, 2025Insider10% owner purchased ~$627K of DMAC shares in the open market

View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Diamedica Therapeutics

OQRO holds no insider, Congress, fund or contract record for Diamedica Therapeutics dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its DMAC page.

Other recent filings by STAHLBERG JAN, 10% owner

The full history of STAHLBERG JAN, 10% owner is on the profile page.

How this filing works

Other disclosures at Diamedica Therapeutics

Everything OQRO holds on this company is on its DMAC page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO Pro Already have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data